Published December 13, 2025 | Version v1

Pharmacotechnological research on the development of a medicinal preparation in the form of granules for comprehensive pharmacocorrection of mastopathy

Description

The aim of the study. To develop the composition and technology of granules based on phytoextracts for complex pharmacocorrection of mastopathy. Materials and methods. During the work, bibliosemantic, marketing, and pharmaco-technological methods of analysis were used.  Results. The research materials are model samples of granules manufactured by wet granulation. The basis was a composition of phytoextracts: dry extract of clover flowers, cranberry fruits, amaranth seeds, and parsley leaves. The quality control of the proposed granule samples was carried out according to organoleptic properties (appearance, smell, taste), granule size, which was determined by sieve analysis, flowability, and moisture content, which was determined gravimetrically. Based on the results of the studies, we developed a technology for the production of granules. Quality control of model granule samples showed that the most optimal samples are those containing sodium saccharinate (№ 2, 3), sugar syrup (№ 2), corn starch (№ 2, 3, 6), 5% starch paste (№ 6), 25% PVP-K30 solution (№ 3), fructose, and aerosil (№ 6). Conclusions. Based on the results of pharmacotechnological studies, samples of the developed drug have been identified as promising for further biopharmaceutical, microbiological, and pharmacological studies.

Files

ZuikinaPalivodaFIN.pdf

Files (526.2 kB)

Name Size Download all
md5:27f565fe282e220c986b1ea5d3761437
526.2 kB Preview Download

Additional details

References

  • 1. Sokolik O, Prozorova G. Current view on the problem of treating fibrocystic breast disease in terms of herbal medicine. Research Results in Pharmacology. 2022. 8:77-85.
  • 2. Yadav P, Sharma A. Management of Fibrocystic Breast Disease: A Comprehensive Review. Journal of Advanced Scientific Research. 2020. 11(4):30-37.
  • 3. Faguy K. Fibrocystic Breast Changes. Radiologic technology.2022. 93:303-315.
  • 4. Mostary S, Hossain M, Maitra T. Response to different medical treatment options for mastalgia in fibrocystic breast disease. Birdem Medical Journal. 2021. 12:22-29. http://doi.org/10.3329/birdem.v12i1.57221
  • 5. Bobritska VV, Strakhovetsky VS, Golovina OV, Kozub TO. Impact on the links of the mastopathy pathogenesis: a view on the pathological cascade correction. Reproductive Endocrinology. 2024. 72-83. http://doi.org/10.18370/2309-4117.2024.71.72-83.
  • 6. Chukhraev N, Zukow W, Vladimirova N, Chukhraeva E, Tereshchenko O. Complementary methods for the prevention and treatment of stress-induced mastopathy. Journal of Education, Health and Sport. 2022. 12:107-122. https://doi.org/10.12775/JEHS.2022.12.08.011
  • 7. Kalitouw F, Manginstar C, Siwabessy M. Fibrocystic Breast Tumor: A Case Report. Medical Scope Journal. 2023. 5:150-153. http://doi.org/10.35790/msj.v5i1.46215
  • 8. Zavizion VF. Fibrocystic changes of the mammary glands: interpretation of the diagnosis, issues of diagnosis and treatment (Literature review). Reproductive health of woman. 2024. 96-102. http://doi.org/10.30841/2708-8731.2.2024.304668.
  • 9. Dubel N, Grytsyk L, Grytsyk A, Sas I. Substantiation of the composition and development of technology of granules based on the Alchemilla subcrenata Bus. herbal extract. Social Pharmacy in Health Care. 2022. 8:11-18. http://doi.org/10.24959/sphhcj.22.254.1
  • 10. Simsic T, Planinsek O, Baumgartner A. Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs. Acta pharmaceutica. 2024. 74:177-199. http://doi.org/10.2478/acph-2024-0015
  • 11. Kumar S, Friend B, Teckoe J, Lad R, Lawrence S, Stewart S. Flexible Manufacturing with Starch-based Excipient Blends for Early-Stage Drug Product Development. British Journal of Pharmacy. 2023. 8. http://doi.org/10.5920/bjpharm.1351
  • 12. State Pharmacopoeia of Ukraine. State enterprise "Ukrainian Scientific Pharmacopoeia Center for the Quality of Medicinal Products". - 2nd edition. - Kharkiv: State enterprise "Ukrainian Scientific Pharmacopoeia Center for the Quality of Medicines". 2015. Vol. 1. 1128 p.
  • 13. Spyrydonov S. The Study of Main the Technological Character Istics of The Granules "SHKT2" Components for Their Use in Gastroenterology Practice. News of Pharmacy. 2012. 1(69):39-41.
  • 14. Monagas M, Brendler T, Brinckmann J, Dentali S, Gafner S, Giancaspro G, Johnson H, Kababick J, Ma C, Oketch-Rabah H, Pais P, Sarma N, Marles R. Understanding plant to extract ratios in botanical extracts. Front Pharmacol. 2022. 13:981978. https://doi.org/10.3389/fphar.2022.981978
  • 15. Busia K. Herbal Medicine Dosage Standardisation. Journal of Herbal Medicine. 2024. 46:100889. https://doi.org/10.1016/j.hermed.2024.100889
  • 16. Adi-Dako O, Kumadoh D, Egbi G, Okyem S, Addo PY, Nyarko A, Osei-Asare C, Oppong EE, Adase E. Strategies for formulation of effervescent granules of an herbal product for the management of typhoid fever. Heliyon. 2021. 7(10):e08147. https://doi.org/10.1016/j.heliyon.2021.e08147
  • 17. Gulab Z, Sampat R, Ingle P. A review on the wet granulation technique and its modules. World Journal of Biology Pharmacy and Health Sciences. 2024. 20:113-124. http://doi.org/10.30574/wjbphs.2024.20.2.0836
  • 18. Brkich GE. Wet Granulation Technology In Industrial Pharmacy. Medical & pharmaceutical journal Pulse. 2022. 24-28. http://doi.org/.26787/nydha-2686-6838-2022-24-5-24-28
  • 19. Hapgood K, Litster J. Wet Granulation Processes. Chemical Engineering in the Pharmaceutical Industry. 2019. http://doi.org/10.1002/9781119600800.ch56